AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 293: H2056-H2063, 2007. First published August 3, 2007; doi:10.1152/ajpheart.00403.2007
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/H2056    most recent
00403.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korzick, D. H.
Right arrow Articles by Saupe, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korzick, D. H.
Right arrow Articles by Saupe, K. W.

CALL FOR PAPERS
Cardiovascular Aging

Local delivery of PKC{varepsilon}-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation

Donna H. Korzick,1,2 John C. Kostyak,1 J. Craig Hunter,1 and Kurt W. Saupe3

1Intercollege Program in Physiology and 2Department of Kinesiology, Pennsylvania State University, University Park, Pennsylvania; and 3Department of Medicine, University of Wisconsin, Madison, Wisconsin

Submitted 31 March 2007 ; accepted in final form 2 August 2007

In adult heart, selective PKC{varepsilon} activation limits ischemia (I)-reperfusion (R) damage and mimics the protection associated with ischemic preconditioning. We sought to determine whether local delivery of PKC{varepsilon} activator peptide {psi}{varepsilon}-receptor for activated C-kinase ({psi}{varepsilon}-RACK) is sufficient to produce a similarly protected phenotype in aged hearts. Langendorff-perfused hearts isolated from adult (5 mo; n = 9) and aged (24 mo; n = 9) male Fisher 344 rats were perfused with {psi}{varepsilon}-RACK conjugated to Tat (500 nM) or Tat only (500 nM) for 10 min before global 31-min ischemia. Western blotting was used to measure mitochondrial targeting of PKC{varepsilon}, PKC{delta}, phospho (p)-GSK-3beta (Ser9) and GSK-3beta in hearts snap-frozen during I. Recovery of left ventricular developed pressure was significantly improved by {psi}{varepsilon}-RACK (P < 0.01) and infarct size reduced in 24-mo rats vs. age-matched controls (60% vs. 34%; P < 0.01). Mitochondrial PKC{varepsilon} levels were 30% greater during I with {psi}{varepsilon}-RACK in aged vs. control rats (P < 0.01). Interestingly, mitochondrial GSK-3beta levels were threefold greater in aged vs. adult rats during I, and {psi}{varepsilon}-RACK prevented this increase (P < 0.01). Mitochondrial p-GSK-3beta levels were also greater in aged rats after {psi}{varepsilon}-RACK (P < 0.01), and subsequent inhibition of GSK-3beta with SB-216763 (3 µM) before I/R elicited protection similar to that of {psi}{varepsilon}-RACK (n = 3/group). Mitochondrial proteomic analysis further identified group differences in the F1-ATPase beta-subunit, and coimmunoprecipitation studies revealed a novel interaction with PKC{varepsilon}. F1-ATPase-PKC{varepsilon} association was affected by {psi}{varepsilon}-RACK in adult but not aged rats. Our results provide evidence, for the first time, for PKC{varepsilon}-mediated protection in aged rat heart after I/R and suggest a central role for mitochondrial GSK-3beta but not F1-ATPase as a potential target of PKC{varepsilon} to limit I/R damage with aging.

ischemia-reperfusion injury; proteomics; mitochondria; senescence



Address for reprint requests and other correspondence: D. H. Korzick, 106 Noll Lab., Pennsylvania State Univ., University Park, PA 16802 (e-mail: dhk102{at}psu.edu)




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. Juhaszova, D. B. Zorov, Y. Yaniv, H. B. Nuss, S. Wang, and S. J. Sollott
Role of Glycogen Synthase Kinase-3{beta} in Cardioprotection
Circ. Res., June 5, 2009; 104(11): 1240 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. N. Peart and J. P. Headrick
Clinical cardioprotection and the value of conditioning responses
Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1705 - H1720.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y. Murozono, N. Takahashi, T. Shinohara, T. Ooie, Y. Teshima, M. Hara, T. Saikawa, and H. Yoshimatsu
Hyperthermia-Induced Cardioprotection Is Potentiated by Ischemic Postconditioning in Rats
Experimental Biology and Medicine, May 1, 2009; 234(5): 573 - 581.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
V. Akoyev, S. Das, S. Jena, L. Grauer, and D. J. Takemoto
Hypoxia-Regulated Activity of PKC{epsilon} in the Lens
Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1271 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nguyen, M. Ogbi, and J. A. Johnson
Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester: IMPLICATIONS FOR F1F0 ATPase REGULATION
J. Biol. Chem., October 31, 2008; 283(44): 29831 - 29840.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Zhai and J. Sadoshima
Overcoming an Energy Crisis?: An Adaptive Role of Glycogen Synthase Kinase-3 Inhibition in Ischemia/Reperfusion
Circ. Res., October 24, 2008; 103(9): 910 - 913.
[Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. V. G. Edwards, M. Y. White, and S. J. Cordwell
The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1824 - 1837.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. O'Brien and S. E. Howlett
Simulated ischemia-induced preconditioning of isolated ventricular myocytes from young adult and aged Fischer-344 rat hearts
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H768 - H777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.